These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 2620689)

  • 1. Endothelium-derived relaxing factor (EDRF): a defence mechanism against platelet aggregation and vasospasm in human coronary arteries.
    Förstermann U; Mügge A; Alheid U; Bode SM; Frölich JC
    Eur Heart J; 1989 Nov; 10 Suppl F():36-43. PubMed ID: 2620689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global myocardial ischemia and reperfusion impair endothelium-dependent relaxations to aggregating platelets in the canine coronary artery. A possible cause of vasospasm after cardiopulmonary bypass.
    Pearson PJ; Lin PJ; Schaff HV
    J Thorac Cardiovasc Surg; 1992 Jun; 103(6):1147-54. PubMed ID: 1597979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets.
    Alheid U; Frölich JC; Förstermann U
    Thromb Res; 1987 Sep; 47(5):561-71. PubMed ID: 3499684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human endothelial cells inhibit platelet aggregation by separately stimulating platelet cyclic AMP and cyclic GMP.
    Alheid U; Reichwehr I; Förstermann U
    Eur J Pharmacol; 1989 May; 164(1):103-10. PubMed ID: 2546782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic inhibition of platelet aggregation by endothelium-derived relaxing factor and prostacyclin.
    Macdonald PS; Read MA; Dusting GJ
    Thromb Res; 1988 Mar; 49(5):437-49. PubMed ID: 3287674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of human coronary arteries to aggregating platelets: importance of endothelium-derived relaxing factor and prostanoids.
    Förstermann U; Mügge A; Bode SM; Frölich JC
    Circ Res; 1988 Aug; 63(2):306-12. PubMed ID: 3260833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets, endothelium-dependent responses and atherosclerosis.
    Mügge A; Förstermann U; Lichtlen PR
    Ann Med; 1991; 23(5):545-50. PubMed ID: 1756024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of methylmercury (CH3HgCl) on the production of endothelium-derived relaxing factor (EDRF) by cultured human umbilical vascular endothelial cells based on its anti-aggregatory effect on human platelets.
    Ohno M; Kishimoto T; Tada M
    Cell Biol Toxicol; 1995 Dec; 11(6):303-11. PubMed ID: 8788207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1987 Sep; 92(1):181-7. PubMed ID: 3311265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercholesterolemia causes generalized impairment of endothelium-dependent relaxation to aggregating platelets in porcine arteries.
    Shimokawa H; Vanhoutte PM
    J Am Coll Cardiol; 1989 May; 13(6):1402-8. PubMed ID: 2784807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin-induced endothelium-dependent inhibition and direct activation of platelet-vessel wall interaction. Role of prostacyclin, nitric oxide, and thromboxane A2.
    Yang Z; Arnet U; Bauer E; von Segesser L; Siebenmann R; Turina M; Lüscher TF
    Circulation; 1994 May; 89(5):2266-72. PubMed ID: 8181152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of endothelium-derived relaxing factor from human coronary arteries using the anti-platelet aggregatory effect.
    Kishimoto T; Fukuzawa Y; Abe M; Hashimoto M; Tada M
    Nihon Eiseigaku Zasshi; 1992 Feb; 46(6):1043-50. PubMed ID: 1556827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1987 Nov; 92(3):639-46. PubMed ID: 3322462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute impairment of endothelium-dependent relaxations to aggregating platelets following reperfusion injury in canine coronary arteries.
    Pearson PJ; Schaff HV; Vanhoutte PM
    Circ Res; 1990 Aug; 67(2):385-93. PubMed ID: 2115821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term impairment of endothelium-dependent relaxations to aggregating platelets after reperfusion injury in canine coronary arteries.
    Pearson PJ; Schaff HV; Vanhoutte PM
    Circulation; 1990 Jun; 81(6):1921-7. PubMed ID: 2344684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis.
    Shimokawa H; Vanhoutte PM
    Circ Res; 1989 May; 64(5):900-14. PubMed ID: 2495869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-derived serotonin, the endothelium, and cardiovascular disease.
    Vanhoutte PM
    J Cardiovasc Pharmacol; 1991; 17 Suppl 5():S6-12. PubMed ID: 1717775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide.
    Tanner FC; Noll G; Boulanger CM; Lüscher TF
    Circulation; 1991 Jun; 83(6):2012-20. PubMed ID: 2040054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of production of endothelium-derived relaxing factor (EDRF) by cultured human vascular endothelial cells based on its anti-aggregatory effect on human platelets.
    Ohno M; Kishimoto T; Jidoi J; Tada M
    Hum Cell; 1994 Mar; 7(1):68-71. PubMed ID: 8025024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelium-derived relaxing and contracting factors: potential role in coronary artery disease.
    Lüscher TF
    Eur Heart J; 1989 Sep; 10(9):847-57. PubMed ID: 2680493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.